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INTRODUCTION
Schizophrenia, or Dementia Praecox, constitutes a
large percentage of all admissions to state hospitals,
and therefore has always demanded an unusual degree of
attention.

Perhaps there is no such type of mental

disease about which there is more written.

This bulk of

discourse in itself is evidence of oonfusion and unoertainty relative to an aooepted understanding.

Sinoe the

disease most frequently affliots individuals just as
they reaoh adolesoence and adulthood, and too, since the
prognosis as a whole is so unfavorable, it is not surprising then, that any new approaoh which seems to thro'M
additional light on the subject is eagerly discussed.
Ignorance of the pathobiologic processes underlying schizophrenia renders therapy directly of the etiologic faotors impossible.

There are, however, accident-

ally discovered. correlations whioh have formed a starting point of therapeutic efforts.

As, for example, in

the case of dementia paralytica, it was noted that ren:dssions coinoided with accidental fevers which led to
the establishment of a biologio antagonism between the
disease process and the febrile condition and thus to
malarial therapy.
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Psychiatrists and others interested in searching
for a more specific therapy for schizophrenia have endeavored to find such coinciding biologic antagonists
which might exist in this disease.

However, without

having an established etiological basis upon which to
work, those making observations in this direction have
not systematized or utilized them for conclusions regarding therapy.
In this paper I propose to discuss the insulin
hypoglycemic shock therapy for schizophrenia.

The

methods and principles of procedure as well as the treatnlent of the shock itself, I quote almost entirely from
1'!lJ'ort is (54) and Glueck (19 and 20).

These are the only

two sources in the literature of this country that discuss this phase to any length.

Of more interest than this

are the results obtained by this therapy and the mechanism whereby these results are brought about.
The methods are those of Dr. Manfred Sakel of
Vienna who introduced this method of treatment.

Wortis,

who visited Sakel's clinic, and Glueck, who reported the
work of Dr. M. Muller of Munsingen, Switzerland, (a coworker of Sakel's) describe the procedure to great detail.

Rather than quote them'to great length, I shall

limit myself to generalizations and devote more time to

staliistics of results, and a review of the literature in
regard to the mechanism of hypoglycemia, emphasizing its
action on nervous

tissue~

At the same time, I shall discuss to a limit, other
methods of medicinal therapy, which, in my opinion, display similar action and results as that of hypoglycemia,
either directly or indirectly.
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INSULIN THERAPY
Appell Farr and Marshall (1)1 in 1929, used small
amounts of insulin in undernourished patients with psychases and reuorted
its .
usefulness to increase weight
...
..... -'

and improve gastro-intestinal function in these individuals.

At the same t irue" they 1 isted nine dist inct ac-

cidental insulin shocks in the course of thirty-one
cases, six of which were in three patients, each having
two.

One of the pat ients with dement ia praecox that

they treated, who had for the previous year refused
weighingl all medicines and physiotherapy, became agreeable and oooperative and so remained.

They failed to

state whether or not this patient was one which had
suffered accidental shock.
During this same year, Meduna (37) states that
Nyiro and Jablonszky in Budapest observed an existence
of a biologic antagonism bet'!'!een schizophrenia and
epilepsy.

They were impressed by the fact that in cases

of long-standing epilepsy in which schizophrenia developed, the epiliptic convulsions ceased or became rare.
Meduna states further that Steiner and strauss in a reon six thousand cases of schizophrenia were convinced
that "typioal epilept io convulsions are so rare in
sohizophrenia, if they ocour at all, as to throw doubt
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upon the correctness of the psychatr ic diagnosis".

In

this same article, it is revealed that in 1930, Muller
published reports of two cases of catatonia in which
recovery ensued after spontaneous epileptic convulsions.
Wortis (54) in introduCing his review of recent
work of Manfred Sakel states that the latter, in 1930,
reported that the abstinence symptoms in m.orphine cures
could be relieved by large doses of insulin.

His hy-

pothesis was that abstinence symptoms were a sign of
general nervous hyperactivity either due to lI(a) nervous hypersensitivity, or (b) excess of the excitant
hormones", chiefly adr(;3nalin.

Sakel used insulin as an

antagonist to paralyze adrenalin action.

Whether or not

this theory is valid, it has proved fruitful in abstinence cures, and has been confirmed by several other
observers.
"The similarity of the abstinence symptoms to
other types of excitement suggested the possibility of
influencing excited states of different origin in the
same way.

The response of several schizophrenic patients

to insulin treatment was favorable enough to encourage
further research.

From the observation of some cases

of accidental hypoglycemic coma and from several theoretical considerations, Sakel ventured to produce
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hypoglycemic, shock deliberately in schizophrenic patients."

(Wortis, 54)

Glueck (19) and Wortis (54) give Sakel the sole
credit for introducing this method of treatment.

Hypo-

glycemic shock is the essence of his method---it distinquishes his procedure from all previous attempts to use
insulin in schiz9phrenia.
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The Method:
The principle of the procedure consists of treating the patients by a regular series of hypoglycemic
shocks whioh are produced by deep intramuscular injections of insulin, and lasting several hours.

The neces-

sary doses are usually, but not necessarily high, and
they vary from 20 to 200 units, and even more.

The

response to anyone dose varies greatly from individual
to individual, and in the same individual at different
times.

Wortis (54) states that twenty units may produce

convulsions in one patient, and "I have seen another
(patient) walk around for hours after an injection of
130 units."
Sakel distinguishes four phases in the treatment,
as outlined by Wortis (54) and Glueck (19); also, Paskind (40).
In phase 1, (preparatory phase), insulin is given
one to three times daily, usually but once a day, 15 to
30 units per dose.

Since the object is to produce a

hypoglycemia, this is started on an empty stomach, and
carbohydrates are withheld for four hours.
is increased daily by 5 to 10 units.

This dose

(Depending on the

physical condition of the patient, Glueck suggests in
some cases of increasing dosage only every second or
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third day.)

This is continued until a hypoglycemic

state with coma is reached.

Thus begins phase 2, in

which one daily dose is given in the morning and consists
of the same amount as that 1.lIJ'hioh produoed the first
shook.

(This may be varied aocording to the reaotion.)

In phase 2, (shock phase) a series of daily, severe
hypoglycemic shocks is produced.
which produoed the first shook.

The dose given is that
This is alterable, but

as a general rule the minimum dosage for producing shook
is preferable.

The patient is then kept at this dose,

reoeiving as :many shooks as are required to bring about
reoovery.

Every seventh day is a rest day, but feeble

patients may require more rest days (Without any insulin).
Some patients have received as high as 60 or 70 shocks
before favorable response was obtained.

The effects in

this stage are notioed three-quarters of an hour to five
hours after the injeotion.

Carbohydrates are fed as be-

fore, and treatment to be terminated consists of glucose
given by stomach tube or intravenously.

Treatment is

terminated after a convulsion.
Phase 3 (rest nhase) is a transition stage between
2 and 4 and consists of one to several days during which
the patient receives very little or no insulin.

Such

interruptions may be called for because of intercurrent

9

febrile and other somatic disorders, or after an epileptic seizure when the patient is usually allowed two or
three days freedom from treatment.
Phase 4 (polarization phase) is referable only to
the cases in which the preoeding treatment led to the
desired result.

It serves as a means of consolidating

and stabilizing the gains acheived.

Much smaller doses

of insulin are administered than in phase 2.

Ten to

thirty units of insulin are the ordinary limits, and the
carbohydrates are administered no later than two hours
after the insulinization.

The patient is not permitted

to reach a deep state of shock, and the treatment is continued until the patient's discharge.
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The

Mana~ement

of Hypoglycemic Shock

Treat~~nt:

Glueck (20) stresses the point that the duration
and intensity of each phase be strictly graduated in
accordance with the requirements of the individual case.
"The most difficult aspect of the entire procedure is
the total unpredictability of the reactions to the bypoglyoemic state in different patients."

He states also

that experience alone with a "thorough-going acquaintance
with the somatic and psychio characteristics of the individual patient are the most dependable guides in this
connect ion".
In phase 1, one is concerned chiefly in watching
for the development of shock.

In the course of this

phase the hypoglycemia manifestations begin to appear,
usually with increasing severity.

They consist of pro-

fuse sweating, increased salivation and yawning with
tremor.

Later, clonic twitchings of the arm and leg

musculature, or the face may develop.

The patient may

complain of varying symptoms from sedative feelings and
slight paresthesias to oppression and pounding of the
heart and double vision.

The amounts of insulin required

to produce shock are extremely variable.

Twelve units

have produced epileptic seizures in one patient

~,vhile

another has remained symptomless with amounts up to 240
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units.

vTIlether or not the patient shows any reactions

indicating shock, Glueck says, "the individual treatment must always be followed by the introduction of the
appropriate amount of carbohydrates."

Patients are

allowed to have fluids during phase 1 and during shock.
Also, during this period> they may prophylactically digitalize for 6 to 8 days.
Phase 2 is the most critical and most important
stage of the treatment.

The patient is in a degree of

stupor or coma with other manifestations of a deep
hypoglycemic state and he is threatened with a convulsive seizure.

Sakel designates the ordinary shock as

"wet -shock If because of the profuse sweat ing which accompanies it, and those patients, according to him, are
most likely to develop epileptic seizure who do not display these customary evidences.

One must be ready in

th is phase to aci'1linister emergency intervent ion of shock.
This is accomplished through intravenous administration
of 30 to 50 per cent glucose solution in amounts of from
100 to 200 cubic centimeters.

Hypodermic injection of

adrenalin and at times, of cardiac and respiratory stimulants is called for.

Glueck (20) states that "the

nasal administration of an adequate
also be carried out".

a~ount

of sugar must
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It is desirable to maintain the condition of shock
as long as possible since it seems to be the profundity
and duration of the coma and the intensity of the affective reaction that determines the therapeutic progress.
On the other hand, the patient's physical condition may
demand the imr2!edia.te neutralizat ion of the hypoglycemic
state irrespective of the requirements of the therapy
of the mental condition.

The intravenous administration

of glucose usually produces the desired effect imrllediately, while Glueck states that the oral or stomach tube
administration of sugar milk brings about the same results in from five to fifteen minutes.

In three cases

that I observed at Douglas County Hospital who were
under the care of Dr. G. A. Young, it appeared to me
that the stomach tube administrat ion brought about a
return to consciousness of the patient almost before the
tube was withdrawn.
There is no general rule as to the number of shocks
the individual patient should receive.

Here again one

should be guided by the progress of the improvement.
Phases 3 and 4 do not need discussion of treatment
because they embody a portion of the management of phase
2.
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In

discussin~
u

the management of the various types
_

-

of schizophrenic patients in regard to shock therapy,
I shall demonstrate variations in handling them later.
Hypoglycemia is ordinarily not prolonged beyond
six hours, or at the very most, eight hours, since protracted hypoglycemia produces irreversible changes, as
will be discussed later.
Wortis (54) generalizes this by saying that shock
should be prolonged until the patient is comatose or at
least somnolent.

,-

lilt should not be terminated during

excitement" unless a patient grows literally wild with
hunger.

Such patients should be fed at once.

He lists

the follo'l,ving indications for termination of shock:

(1)

collapse, irregular pulse or bradycardia under 35 to 40
beats per minute; (2) sudden marked fluctuations in
pulse rate up to ISO. and down to 90 beats per minute for
example; (3) laryngospasm; (4) tonic cramps or contractions; (5) epileptic seizures; (6) respiratory disturbances, such as Cheyne-Stokes, stertorous, or brochspastic breathing."

Simple psychomotor excitement,

cyanosis of arms and legs, or myoclonic twitchings are
not indications for termination, in his estimation.
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The Cause and Mechanism of Hypoglycemic Shock:
The signs of hypoglycemic shock have been frequently described.

Early observations drew attention from

time to time to chemical substances which were thought to
accumulate and be responsible for these signs.

Best (4)

is convinced that there is no evidence that a toxic chemical substance accumulates when the blood sugar is maintained at low levels.
I shall enumerate the theor ies for the mechanism
of the neurologic symptoms as I have found them in the
literature, as follows:
Anoxemia the ory;
Holmes (25) reveals that the various types of tissue
that compose the central nervous system in mammals have
a different rate of oxygen oonsumption, and that the activity of gray matter is in this respeot far greater than
that of white matter.

"The term 'gray matter' neoessar-

ily includes without discrimination both nerve cells and·
synaptic junctions."

He continues with lithe greatly in-

creased oxygen uptake whioh gray matter displays in the
presenoe of gluoose is dependent upon the oonversion of
the gluoose to lactic acid, and disappears if this oonversion is prevented by flour ide . It

He feels that oarbohy-

drate is probably not responsible for any considerable
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part of the oxygen uptake of nerve, "but this statement
n,ust oarry the reservation that little or nothing is
known of the part played by oarbohydrate fraotion of the
oerebrosides ",
Dameshek and Meyerson (11) oompared the oontents
of dextrose and oxygen in the vessels supplying the
brain before and after the administration of insulin,
They found that lithe ohemioal ohanges in the blood
usually varied direotly with the severity of the reaotion,---and that the uptake of oxygen by the brain varied
indireotly with the severity of the insulin reaotion,
beooming much reduced during the most severe reaotions",
From this evidence they oonoluded that if the diminution
in the arteriovenous differenoe in the oontent of oxygen
during the insulin reaotion may signify aotual diminution
in oxygen uptake by the brain, then the meurologic
symptoms of the severe hypoglyoemia may be due to the
effeots of a laok of oxygen on the brain tissue.

These

authors agree 'Ni th Holmes in that' oxygen oonsumed by the
brains of insulin-treated animals is less than that
oonsumed by normals.

However, they make it plain that

there is a very definite oxygen consumption still taking
plaoe even though there is very little lactio aoid
available.
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Dameshek and Meyerson (ll) in quoting Olmstead and
Logan said that the latter found that fldecerebrat ion and
decapit~tion

experiments on cats might indicate the ori-

gin of the insulin convulsion was probably in the medulla, more specifically in the respiratory center".

These

observers were impressed with the possibility that
through the lowering of the blood sugar certain oxidative processes become :iepressed to such a degree that
the brain cells are affected in much the same manner as
asphyxia.

Also l "Kleitman and Magnus, in experiments

on rabbits found that hypoglycemia led in some way to
an irritation of the medulla and thus to convulsions ll ,
even though they noted "arterializat ion of the blood.
This, together with the well-known sensitivity of the
brain to diminution in its oxygen supply, may account
for such phenomenon as tremor, twitchings and convulsions,
the end result of the lack of oxygen being coma."
Lennox (32), in

reuortin~
~

his data on the

aver~e
~

respiratory quotients of the various portions of body
represented, found that they differed w'idely.
sults were:

His re-

(1) Brain, 0.95; (2) Arm, 0.86; (3) Leg,

0.72.

Rudy (44) in speaking of Dudley and Laufberger and
their work on mammals said that these observers showed
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a marked. deorease in oxygen oonsumption during severe
and prolonged hypoglyoemia whioh is derived from the
faot that the venous blood is br ig;ht red dur ing the insulin reaotion.

Rudy, however, feels that "diminished

oxygen oonsumption does not neoessarily mean anoxemia,
but may be explained by the deorease in oxidation of
oarbohydrates beoause of the laok in gluoose, and by
the hyperseoretion of epinephrine."
Epinephrine and sympathetio nervous oontrol theory;
Best (4) states the "epinephrine causes a prompt
mobilization of liver glycogen and probably later the
conversion of muscular glyoogen to laotio aoid which is
in turn oonverted to dextrose or glyoogen, or both, in
the liver."
Cannon, McIver and Bliss (7) demonstrated that
exoitation of the sympathetio nervous system oocurred
with marked hypoglycemia.

They state that if the blood

sugar falls below a oritioal point in oonsequence of a
defioienoy, the splanohnic neurons of the sympathetio
system are set in aotion as indicated by increased
suprarenal seoretion.

Both the nerve impulses and the

inoreased seoretion of epinephrine have the effect of
liberating sugar from the liver into the Circulation,
thus tending to restore the equilibrium.
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Brooks (6) found that surviving spinal cats with
the cord transected in the cervical region have a diminished resistence to insulin.

Hypoglycemia activates

the sympathetic system of a spina,l cat to such an extent that, while 0.5 unit of insulin per kilogram is
never fatal to a normal cat, and usually one

08,0

reoover

from 1.0 unit per kilogram, the "spinal animals in which
the adrenals have been inactivated cannot recover spontaneously from O. 5 unit of insulin per kilogram".

He

concludes that "hypoglyoemia causes strong sympathetiooadrenal act iv1 ty in nortr18.,1 cats can likewise induce
act ivi ty of this system in a spinal cat ".

Ris results,

he feels, afford further evidence for the existence of
a spinal mechanism which is capable of exerting some
influence upon the peripheral adrenal system because
even though convulsions are eliminated 'by

oervio~l

tran".,.,·

section of the cord, other hypoglycemia symptoms occur.
Rudy (44) believes that lithe low blood sugar activates the sympathetic nervous system and causes a
hypersecretion of adrenaline

The increased epinephrine

secretion promotes a glycogenolysis which causes a
gradual elevation of the blood sugar and relieves the
symptoms.

If, however, the blood sugar continues to

remain low because of the overdose of insulin, its
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effect continues and additional symptoms develop, such
as convulsions and other neurological as ','\Tell as mental
symptoms".

From this evidenoe, he concluded that the

early signs of shook were due to epinephrine response,
but that the coma and later signs were due to the drop
in blood sugar, and he failed to state why this caused
s Yl1lpt OrhS _

Dameshek and Meyerson (11) are opposed to the
epinephrine theory_
periments showed:

The data brought out in their ex(1) the diminution of the tremor and

perspiration of the insulin reaction after the injection of epinephrine; (2) lack of dilation of the pupil
during the insulin reaction; (3) the striking difference bet"ween the type of effect produced by insulin
and that by eninenhrine on the ohemical constituents of
.1.,.

,"

the blood."
Dworkin (13) showed that "bilateral extirpation of
the sympathetio nerve ohains render cats permanently
hypersensitive to injected insulin."

In these animals,

the blood sugar curves after insulin injection show a
rapid and precipitous decline, with no evidence of a
spontaneous recovery.

Restitution to normal was brought

about with the use of epinephrine or glucose.

20

Disturbed water balance theory;
Dameshek and Meyerson (11), although they do not
consider this phase as a very likely cause for symptoms
in hypoglycemia, mention its possibilities.

They state

that Olmstead and Taylor concluded from studies of the
oxygen capacity of the blood that the blood became
concentrated \vhen the blood. sugar reached its lowest
level, while Rathery and Sigwald found a constant elevation of the plasma chlorides and a decrease in the
spinal pressure in dogs with insulin hypoglycemia.
However, Drabkin and Ravdin disagreed when they found
that the cerebrospinal fluid pressure in dogs rose with
the fall in blood sugar.

"On the basis of these and

previous experiments they found that insulin convulsions
were caused by an increased cerebrospinal fluid pressure resulting from anhydremia.

It is conceivable that

the edema of the brain described by Schereschewsky in
animals, and by Bowen and Beck in a human case, might
be secondary to a disturbance in oxidative mechanisms
in the brain and not a primary manifestation."
Cerebral malnutrition theory;
Rudy (44) believes that "in hypoglycemia, the
brain cells suffer a lack in nutrition because of the
10'.v blood sugar.

11

He feels that the neurological and
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symptoms which occur in the first stage of the insulin
reaction are due to the effect of epinephrine on the
vascular system.

If no organ damage occurs, the recov-

ery is rapid and complete.

The drop in the blood sugar

with its by-effects is the chief factor in the production of the symptoms of the insulin reaction.

There are

two stages in the hypoglyceffiias of any origin.

They are

both brought about by the drop in the blood sugar."
Dameshek and Meyerson (11) found that the uptake of
dextrose by the brain became materially reduced during
the severe hypoglycemic reaction, although that of the
arm usually became increased, and that the blood lactic
acid became increased during the reaction, no differences between vessels being noted.

"There was no essen-

tial change in the dextrose content of the spinal fluid
during the period,of observation."
Ravid (43) proposed that the action of transient
insulin hypoglycemia "may be initiated directly by
insulin itself or by the still unknown intermediary products of oarbohydrate metabolism that it produces, as
by creat ing, as it were, a 'vacuUln' for glucose in the
nerve tissues or

by

a process similar to this.

The re-

sulting effect, then, may manifest itself by alteration
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of function of either the nerve elements themselves, or
the blood vessels supplying them."
Rudy (44) mentions that MacLeod "presented good
evidenoe in favor of nervous control.

He demonstrated

that convulsions did not occur in a denervated muscle,
even when the blood sugar dropped and convulsions were
present in other muscles with intact innervation."
There is evidence that animals that are anesthetized, or who have cervical transect ions of the cord,
do not show convulsions.
Powell (41) is also of the opinion that the symptoms are due to cerebral malnutrition.
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Effects of Hypoglycemia Shock:
Ravid (43) described a transient hemiplegia as a
result of insulin hypoglycemia.

"The symptoms seen are

shivering, perspiration, loss of consciousness, convulsions with conjugate deviations of eyes and head to
right, contraction of muscle of lips, cyanosis of face--symptoms and signs which are indicative of a definite
cerebral involvement."

He says that these are classical

features of those seen in a lesion of the internal capsule and also involving the retrolecticular portion of
the posterior limb.
Carr (8) states that "no matter what the cause,
hypoglycemia may be manifested by stupor, amnesia,
muscular twitching or convulsions and a number of other
less striking symptoms such as restlessness, weakness,
anxiety and fatigability,"
The first signs of hypoglycemia appear to be due to
an epinephrine response.

Harrop (22), in discussing

the toxic effects of insulin differentiates between
mild reactions and severe reactions.

The former are

subjectively typified by a sense of weakness that is
generalized and referred to the abdomen, feeling of
trembling, and a sensation of coldness in the extremities
and a numbness of the lips.

Objectively, they display
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pallor, sweating, moderate rise in systolic blood pressure, and the pupils are dilated.

The severe reactions,

he states, may simulate alcoholio intoxioation by showing weakness and dizziness, sweating, mania or excitement, and delusions, obsessions and hallucinations; or
there may be loss of consciousness "ith semi-stupor or
stupor, and coma.

"A oharacteristic feature of these

attacks is the complete amnesia whioh the patient exhibits after reoovery.

His reoollection is usually re-

tained up to the moment when symptoms appear, and then
it is lost completely."
Ernstene (14) noted that the "pulse rate and pulse
pressure increased during hypoglycemia (the systolic
pressure rises, and the diastolic falls) and the minute
volume output of the heart increased during this state.
Rudy (44) is of the opinion that "the pallor, profuse sweat, increased pulse rate, elevation of blood
pressure, vascular spasms and dilatations are brought
about by the activation of the sympathetic nervous system and the hypersecretion of adrenalin".

Furthermore,

"the neurological and mental symptoms, which occur in
the first stage of the insulin reaction, namely in the
stage of the hypersecretion of epinephrine, are due to
the effect of epinephrine on the vascular system."

25

He states that in Addison! s Disease, the pat ients do not
develop the first stage due to epinephrine, but immerse
directly into the stage of central nervous system, hyperirritability with convusive seizures and unconsciousness
because of no compensatory epinephrine action.
Wauchope (50) in reviewing the effects of hypoglycemia states that tlgross symptoms are headache and
fatigue.

The bulbopontine system gives rise to disorders

of speech such as stammering, difficulty in forming words
and slow articulation" when it is affected by disturbed
function.

tlOoular disturbanoe suoh as double vision,

nystagmus, inequality of pupils, but rarely deafness"
are also manifestations of hypoglycemia.

"The oortioo-

spinal group comprises paralysiS, Babinski sign, aphasia,
perseverat ion, apraxia, motor irritability, inooordination, trismus, twitchings and oonvulsions which may be
tonic or olonio (localized or general) and may resemble
an attaok of epilepsy.

There may also be disturbances

of smell and taste or paresthesia of the tongue, but very
rarely incontinence of urine or feoes."

Tremor, ohorei-

form movements, fibrillary tWitohings, grimaoing and
rigor of muscles belong to the stria-thalamic system
when it is disturbed.
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Grayzell (21) showed that in rabbits which had been
sub:iected
to severe convulsions one or more times showed
...
lesions in the cortex, particularly in the pyramical
cells of the third and fifth cortical layers.

The milder

reactions consisted of zones containing shrunken, hyperchromactic cells with cork-screw processes, wbile the
more severe lesions showed, in addition, zones of necrobiosis.

The greater the number and the more prolonged

the convulsions, the more severe were the lesions.

He

also states that "Speilmeyer showed that focal anatomic
lesions of necrobiotic type in the brain can result from
a purely functional circulatory disturbance."

Convul-

sions associated with a variety of intoxications without any organic occlusion of a cerebral artery can well
be regarded as due to vasomotor disturbances.
In a report of the meeting of the Societe mediclpsycholog1que (29), Schmid of Munchenbuchsee spoke on
the histopathology of insulin shock and reported on experimental work on rabbits, and found that the changes
in the nerve tissue were much less marked than anticipated.

Even though the eleven rabbits received daily

injections of insulin at the rate of 2 cubic centimeters
per kilogram of body we ight, there were I;no destruct ive
lesions, hemorrhage or edema found, only tumifaction.

27

The changes were those of a capillary hyperemia due to
the epinephrine response to the insulin treatment."
Bersot of Neuchatel described the neurologic syndrome of
insulin shock.

"Following injection, the patient, before

becoming more or less deeply comatose, can present all
sorts of cortical, pyramidal, extrapyramidal and vagosympathetic symptoms.

One most oommonly observes tonic

rigidity, olonio twitchings, more or less uncoordinated
movements of the face and trunk, catatonic attitudes,
stereotyped gestures, attaoks of oonvulsive epilepsy,
abolition of one or all reflexes, excessive perspiration and salivation, vasomotor disturbances, and a
bradycardia down to 50."
Glueck (20):

"When the patient reaches this shock

phase the somnolence passes into a coma of greater or
less depth, the normal reflexes beoome abolished, pathologioal reflexes take their place (Babinski, Oppenheim,
etc.) and finally there sets in a total abolition of all
reflex aotivity.

Occasionally one observes a transitory

hemiplegia, which, like the asphasia that may develop
on awakening, disappears after a short time.

It

Paskind (40), in a synopsis of Finkleman and Stephans' observations says that they concluded, because of
the abnormal reactions of schizophrenic patients to cold
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and heat, that there is a similarity of these findings
with those in animals with a lesion in the hypothalamus.
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Effect of

ins~lin

shock

th~rapy:

Freeman (15) and Kasanin (30) agree that schizophrenia is characterized by normal fasting blood sugar
levels, and that the average curve falls well within
normal limits, but the individual variability and the
percentage of abnormal sugar curves are greater than in
normal subjects.
Appel, Farr

~~d

Marshall (1) say that there is no

difference in the blood sugar reactions to insulin between 'those patients with affective and those with
schizophrenic psychoses.
Rapheal and Parsons (42) are of the opinion that
among the cases of dementia praecox, tolerance curves
vary according to the phase of the clinical course, the
older cases tending to show a more nearly normal curve.
The blood sugar tolerance curves of 28 sohizophrenic oases
studied, showed 60.7 per cent abnormal ourves when they
were evaluated by the olimax of the hyperglyoemia.

When

estimated by the hyperglyoemio area, the value was 72.7
per oent.
Glueck (20) states that apart from the well-known
fact of the individual differences in sensitivity to
insulin, the differences in the symptoms which appear in
the hypoglycemic state seem to determine the degree of

30

reactivity of the insulin anta~onists (adrenalin,
pituitrin) which affects in turn the progress of the
hypoglycemic state.

(Best (4), mentions that thyroxine,

adrenal cortex, and anterior pituitary substance are
also antagonists to insulin).

In cases with considerable

muscular irritability and excitement the tendency towards
adrenalin neutralization of the effects of insulin is
greater.

"Muller is of the opinion that the pat ients

are9.ble to exercise considerable volition in the matter
of permitting themselves to sink into the deeper phases
of the hypoglycemic state," and "according to Sakel, old
cases of schizophrenia seem to be more resistive to the
influence of insulin than recent cases,"
Glueck (20) continues by drawing attention to Sakel's
hypothesis that the hypoglycemia supresses the momentarily most active part of the psyche, and thus makes possible
the emergence of the latent aspects thereof, which then
supplants to a greater or less extent the acute existing
manifestations which have already been repressed by the
insulin.

tlBefore the stage of complete coma is reached,

the hypoglycemia inhibits and delimits the existing
(psychotic) state and converts it into its opposite
(insofar as one might speak at all of oppos i tea ~ • tl

Sakel

has observed in many patients that if one is delusional
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or halluoinated, he would often manifest a brief period
of oomplete ludioity just before falling in a deep ooma,
but the same patient later on, after there had been a
progress far enough to enable him to behave quite normally when not in hypoglyoemia, would, during the shook,
beoome aoutely psyohotic

~~ain

sinking into deep coma.

He calls this "the activated

psychosis."

for a brief period before

There appears to be a strong tendency to

the fixation of the condition which exists at the time
of the interruption of the hypoglycemia.

"The interven-

tion of the shock in the case of an excited catatonic during a state of calm and passivity would tend to establish a similar condition, also, for the non-hypoglycemic
phases.

Conversely, in the case of a stupor, the inter-

ruption of the shock during a state of activity and excitement, would tend to continue to activate the patient
outside of his hYpoglycemic state."

Therefore, Sakel

advocates that the original technic holds good for paranoid types of schizophrenia, while stuporous patients
receive the most benefit when the hypoglycemia is interrupted at a suitable time during the second phase of the
therapy, when there are indications of activation.
Roughly, excited catatonic types should be allowed to
progress to coma that is more deep.

However, the latter
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type of patient responds the least favorably to treatment, while the paranoid patients show the best progress,
repea.tedly.
Glueck (20) continues by saying that Sakel adheres
striotly to a bioohemica1 hypothesis ,\lV'ith whioh he endeavors to sum up the explanation of the dynamios and
modus operandi of this therapy.

1. The insulin puts a

barrier between the cell and external stimuli, thus putting the cell at rest and enabling it to recuperate.

He

assumes that by keeping the pathologically conditioned
oe 11-pathways in abeyance, the or igina1, normally conditioned pathways have a chance to re-establish themselves.
2. The profound, almost annihilating assault whioh the
cell experiences during the insulin shock perhaps actually eliminates the recently established pathologioal pathways, and in the course of recovery from the shook, only
the older, well-established pre-psyohotic pathways become re-animated.

A general detoxication of the entire

organism through the effect of the insulin on the entire
metabolic status.

It

Sakel assumes a progressive develop-

ment in the cell of pathi1llays which are spec ifie to certain stimuli, and in time there develops a sort of
Ithierarchy of pathways" the older in time of origin
naturally being the more resistive to insult.

"Through
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the elimination of the existing contemporary pathological pathways, the older, normal ones have a chance to
reassert themselves and adaptation to reality becomes
normal again.

II

Wortis (54) in explaining this further suggests
that "insulin inhibits and blockades the nerve cell, so
that the nerve pathway patterns, like jurymen locked in
a room, finally come to order.

The seat of action, he

(Sakel) believes, is the vegetative centers."

Wort is ,

own view is that schizophrenia may be a symptom of
nutritional disturbance in the brain.
Marquart (35) concludes that "patients with acute
schizophrenia show greater inability to maintain the
steady physiological state than do patients with quiescent and chronic schizophrenia, II and "it would seem that
the best eXplanation of this variety of organiC disor,der
is neither of a primary somatic nor of a psychogenic
cause, but of an intimate interact ion of both so that
the total organism reacts in a thoroughly, disorganized
and incoherent manner, intellectually, emotionally and
physiolo~ically."
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Results of Insulin Hypoglycemia Therapy:
Since Sakel first introduced this new form of
therapy at Professor PotzllS Clinic in Vienna, it has
been employed in private and public mental hospitals in
Switzerland, in the Netherlands, in Poland, in isolated
German clinics, in Russia and in Japan.

Wilson (51)

has suggested that Great Britian investigate and consider the treatment very seriously.

There are very few

reports available in the literature of this country, but
it is quite evident that many institutions and clinics,
as well as private clinicians are using this method
of therapy.

At the present time, Sakel is in New York

state demonstrating his methods and technic, and has
patients under active treatment.
From time to time, there have appeared articles in
the journals with results quoted by various observers.
Wortis (54), and Glueck (19 and 20), who have been visiting the olinics of Sakel, Dussik, and Muller in Vienna
and Munsingen, have reported earlier on the results of
the latter's work, and their own observations.
By November 23, 1936, at the meeting of the Societe
medicl-psyohologique of Paris (29), the time was devoted
to a symposiu.m by visiting and looal alienists on the
insulin treatment of sohizophrenia.

"Muller of Munsingen
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reported the experience in 300 cases in Vienna and
Switzerland.

There were only four deaths, and these

were due to organic disease associated with the mental
disorder.

The results are grouped according to the dura-

tion of the disease:

Group 1, disease of less than six

months' duration; 89.8 per cent improved, including 73
per cent completely cured.

Group 2, disease of more

than six months' duration; 82 per cent improved, including 50 per cent completely cured.

Group 3, disease of

more than eighteen months' duration: 45 per cent improved, but including only 0.5 per cent complete cures."
These later reports are improvement over earlier
ones as stated by Glueck (19), who quoted Dussik and
Sakel's first available statistics on 104 cases.
agree with Paskind (40).

These

These cases consisted of fifty-

eight recent ones (duration of under one-half year) and
forty-six older ones.

In the group of fifty-eight re-

cent cases, a good recovery was made in 88 per cent,
enabling these patients to resume former occupations in
the community, while 70.7 per cent attained a complete
recovery.

In the group of forty-siX older cases (dura-

tion of illness more than one-half year) a good social
recovery was made in 47.8 per cent, whereas a complete
remission was attained in 19.6 per cent of the cases.
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Wortis (54 and 55) quotes results in Sakel's clinic
on ninety-five cases.

His reports are very similar to

those aforementioned.
Dr. G. A. Young, and Dr. R. H. Young of Omaha have
over thirty cases treated or under treatment.
of their work are forthooming.

The reports

At the present, they be-

lieve that the therapy has merit.
Dr. F. G. Ebaugh of the Colorado Psychopathic Hospi tal has five oases under treatment, and four cases have
been disoharged with favorable results.

He plans to con-

tinue very careful follow up studies on these oases.
Dr. Steinfeld (46) reported on three "old" cases
and reports favorable results on them.
Wilson (51) in gathering statistics for the Board
of Control for England and Wales reports that Lichter of
Lugoi reported 9 cases, all of whioh showed no favorable
response to treatment.

Ederle, of Giessen, treated 15

oases and reported quiok remission on new patients, and
the old oases were "favorably" influenoed.

From Tagreb,

five patients were disoharged out of twenty oases,

Kubo,

of Keijo, Japan, reported good results with 17 oases,
while Rose, of Vilna, Poland had "good" results on 19
oases.

Anderson of Antwerp, had a "few" cases with

"favorable" results.
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Wilson continues with "all researches taken together, spontaneous remissions are found at most in 20
to 30 per cent of cases (with schizophrenia).

Natural

remissions in acute cases rise over 50 per cent, and in
old ones are under 10 per cent."

Among the complications

of insulin treatment are mentioned bradycardia, tachacardia, pancreatic damage, alterations in sugar metabolism after shock, urticaria, laryngeal spasm, low temperature, aspiration of saliva and other material, and mental sluggishness.
There is no accurate report of the death rate other
than that of Sakel and that of Muller, and these are
carried only up until December, 1936.

Those of the

latter have already been mentioned (four in number).
Sakel, in his first 104 cases, reported three deaths.
(J. A. M. A. 26 )

Some corrm.'lent in the Journal of The American Medical
Association (J. A. M. A. 27) issued warning that premature enthusiasm in relationship to this method should
not be released.
Strecker (47) in defense of insulin therapy has
this to say:

"The methods of treatment for schizonhrenia
..

have been so numerous as to invoke scepticism against any
new method, however well supported, but it is equally
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true that malarial treatment of G. P. I. was greeted
with the same misgivings.

The fact that early cases do

so well with insulin therapy does not imply that the
same patients would have made an equally good recovery
without such treatment."
The therapy is more efficient if administered soon
after the illness begins.

Sakel believes that the per-

centage of perfect remissions appears proportional to
the duration of the illness.

If the illness is present

a long time, it seems that insulin shock therapy is
unable to waken the physiologically inactivated and
atrophied intelleot.

In full remission, recovery is

effected and the patient is restored to society.

When a

good remission is obtained, it appears that the process
is at least arrested.
Sakel, as stated by Paskind (40), has followed a
number of patients for over a year who responded to the
insulin therapy.

"Of those with complete remission, 15

rel:1ained \'Vell over a year; and 34 over a half year.

In

the new cases, three cases of full remission, five of
good remission and one of social remission have been
followed by recurrence.

In the others, 42 of the new

oases show a good unchanging condition.

Among patients

with recurrences, five were retreated, three of whom
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gained good remissions, one showed no results and one
is still being retreated.

Of those of the old cases

with recurrence, six were retreated, one of whom gained
a good remission, one a full remission, two social remissions, one showed no results and one is still being
treated. .. fI
From the figures for remissions after this treatment, it appears that they are in marked contrast to any
published statistics on spontaneous remissions, that
there is no doubt that insulin shock therapy for
schizophrenia has superior worth, at least for acute
cases.

Just how long these remissions will last can be

revealed only by observation in time.
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THE VALUE OF SMALL

M~OUNTS

OF INSULIN IN SOHIZOPHRENIA

In surveying the litera.ture for statistios oonoerning insulin therapy for schizophrenia, I found several
articles which indioated that insulin in small doses
played a part in the treatment of this disorder, three
of whioh I will reiriew here.
Appel, Farr and Marshall (1) in their series of
treatments, show that small amounts of insulin are very
useful to inorease weight, appetite, and to improve gastro-intestinal funotion in all the psychoses.
Munn (39) states that "Bulatao and Carlson noted
that the injection of insulin inoreased the motility of
the stomaoh in the normal fasting dog.

Campbell wrote:

tIn intraotable anorexia from various causes, hunger may
still be induced with insulin when other measures completely fail.

t

It has been proved that insulin stimu-

lates the gastrio, biliary and pancreatic secretions."
Munn administered to five patients with catatonic stupor
an average of thirty units of insulin per day for forty
days without variation of the routine diet or the environment.

As a result, "two patients showed no change

in the olinioal oondition, either mentally or physically.
The remaining three, whose psychoses were all of relatively aoute onset, of short :iurat ion and assoc iated with
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definite emotional precipitating agents, showed the improvement that is commonly observed in persons with this
type of condition, with insulin treatment or without it."
He concluded that it was impossible to estimate the influence of insulin therapy on the patients.
Bennett and Semrad (2) placed 25 Psychatric patients
on high caloric diets and gave them small doses of insulin for malnutrition, and compared them with 25 cases not
receiving insulin therapy, other conditions being equal.
They found "an average of .423 pounds per week excess
gain was found in the cases that had received insulin
treatment. "
AndWortis (53) describes the rapid disappearance
of the schizophrenic patient's facial acne lesions who
had under-gone insulin shock treatment (six cases).
"The improvement appeared long before shock doses were
reached.

A relapse of the patient's skin condition oc-

curred COincidentally with a relapse in the patient's
mental state in the course of treatment.

In the more

n:.arked hypoglycemic reactions, the skin is probably
benefited by a cutaneous hyperemia and profuse sweating
that insulin coma provokes. --- It is possible that both
schizophrenia and acne are associated with some common
disturbance of carbohydrate metabolism, which is in turn,
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benefited by protracted insulin hypoglycemia.

It is

also possible that the compensatory production of epinephrine which insulin hypoglycemia provokes may be another factor involved."

,-
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NEW METHODS OF MEDICAL TREATMENT OF SCHIZOPHRENIA
Method by induced epileptiform convulsions:
Meduna (37), using a 25 per cent oily solution of
camphor in intramuscular injections, raising the dose
from 8 to 30 cubic centimeters, and later using metrazol
in 10 per cent solution, intravenously in doses of from
3 to 7 cubic centimeters, deliberately produced epileptiform convulsions in patients.

After administration of

camphor, the reaction occurred in from one to two hours,
while after introduction of metrazol, the convulsio?s
appeared immediately.

The convulsions produced by the

two substances were similar, but metrazol, he thought,
was more suitable.

Of forty-three male patients treated,

"nineteen patients were cured, seven

~howed

improvement

and the condition of seventeen remained unchanged.

In

the wards for female patients similar experiments have
been carried out with camphor.

Of thirty-one patients

there, ten were cured, four showed improvement and the
condition of seventeen remained unchanged.

Summing up,

Dr. Rath and I have treated altogether seventy-four
patients, of whom twenty-nine (39 per cent) were cured,
eleven (15 per cent) showed improvement and the condition of thirty-four (46 per cent) rema.ined unchanged,"
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Meduna observed that the likelihood of oure is proportionate to the patients' liability to oonvulsions.

He

states further that "the peroentage of oures far exceeds
the number of spontaneous remissions reoorded in the literature.

There were relapses in which the prompt appli-

cation of convulsive therapy led to a remission on the
day following the convulsion.

It

He feels that "the ef-

fect of the epileptic convulsions changes the chemical
constitution of the organism in the way suitable for the
cure of schizophrenia.

Similar remissions of schizo-

phrenia are not unknown, e.g. remissions preceding death,
explainable by nothing but a preagonal change in the
chemical milieu of the organism at the beginning of dissolution."
Carbon dioxide and oxygen therapy in Schizophrenia:
Henry (23) demonstrated that "practically all of the
motor phenomena characteristic of human catatonic can be
duplicated in the higher animals by means of injections
of bulbocapnine in doses varying from 5 to 10 per cent
of body weight.

The extent to which catatonio manifes-

tations may be produced is directly related to the degree
of development of the neocortex."

Dr. Langenstrass, in

commenting on these results said that inhalations of
mixtures of carbon dioxide and oxygen produced regularly
a transient disappearance of the catatonic symptoms.
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Loevenhart, Lorenz and Waters (33) found that sodium
cyanide administered intravenously in proper dosage
caused a cerebral stimulation in the stuporous phase of
certain psychoses, and that a mixture of carbon dioxide
and oxygen inhaled in a described manner is a far better
agent for producing such cerebral stimulation.

"By

these simple chemical procedures, the mental processes
in certain psychotio patients are restored toward normal for a period of from two to t1!\Tenty-five minutes.
These observers offer the

follo~ing

as symptoms of var-

ious levels of oxygen fixation:
1. Inoreased oxygen fixation:

2. Normal oxygen fixation:

depression.

normal aotivity.

3. Deoreased oxygen fixation:

inoreased

psychic activity.
4. Further decreased oxygen fixation: stimulation, principally of motor cortex, often
with maniac-like stimulation of psychic
activity.
5. Greater decreased oxygen fixation:

depres-

Sion, anesthesia, paralysis (reversible).
6. More severe decreased oxygen fixation:
death (irreversible).

II
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Solomon, Kaufman and D'Elseaux (45) acknowledge the
fact that bulbo-capnine produces cataleptic-like effects
in animals, and they supposed this chemical substance to
affect the cortical areas.

Carbon dioxide administered.

showed results analogous to carbon dioxide in patients
with cataleptic psychoses.
cated.

II

"The cortex must be impli-

From the experiences with -the carbon dioxide

and oxygen mixture"

If

one cannot avoid a cons iderat ion of

a possible direct stimulation of the cellular structure
by carbon dioxide, because carbon dioxide is reputed to
act as a specific stimulant to the cells of the respiratory centers, and therefore may likewise act as a specific stimulant to cerebral cells. II

They are prone to

consider the possibility of stuporous disorder being in
the subcortical or extra-pyramidal system.
D'Elseaux and Solomon (12) arrived at no definite
conclusions concerning the effects of carbon dioxide
administration to schizophrenic patients, but they believe that the remissions, if any, are due to stimulat ion of body economy and psychic ch,anges not est imatable.

Bennett (3) states that "ueriods of luciditv. have
~

been reported by several experimenters ranging from five
minutes to four hours immediately following the treatment of carbon dioxide administered.

The amounts given
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vary from 5 per cent to 50 per cent, and administration
time from 30 seconds to 30 minutes."
Loevenhart (33) believes that a "true cerebral
stimulation is brought about by reduced oxygen fixation
in cerebral cells."
Leake, Guidel and Botsford (31) state that:

1.

Carbon dioxide depresses the oxygen dissociation curve
making oxygen in blood more available to tis$ues.

2.

Cells use more oxygen in the presence of carbon dioxide.
3. Cortical cells in dementia praecox may be depressed
by a relative asphyxia.

4. Carbon dioxide temporarily

facilitates the restoration of functional oxidation in
cortical cells, leading to anesthesis, so when it is
withdrawn and the relative asphyxia returns, there is
temporary stimulation of those cells due to oxygen want.
Prolonged sleep treatment in Schizophrenia:
At the Second All-Union Conference of Psychiatrists,
February 2, 1937> (29), Professor Ostankov of Moscow
noted that Schizonhrenia is far from being as common as
~

it is now diagnosed.

~

"This diagnosis has been made too

easily by neurologists and psychiatrists iVithout enough
justification."

The sleeping treatment of schizophrenia

lIintroduced by the late I. P. Pavlov was discussed by
Prof. A. S. Ivanov-Smolensky of Leningrad.

If cortical
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nerve cells are strongly stimulated for a prolonged period, they go into a state of inhibition.

Pavlov concluded

that in cases of stupor there exists a diffusely spread
st irm.llat ion in the central nervous system.

This inhibi-

tion preserves nerve cells from destruction.
sleep method was elaborated.

Thus the

It consists of putting the

patient to sleep for from five to twelve and a half days
by narcos is.

II

Bleckwenn (5) used sodium isoamylethylbarbiturate
intravenously in over 50 cases of all types of psychoses.
The dosage var ied from 7 to 15 grains.

"Normal lucid

intervals with spontaneous speech and the taking of
nourishment are seen in protracted cases of catatonic
dementia praecox lasting from 7 to 18 hours."
thoug~.that

He also

sodium amy tal is extremely valuable in pro-

ducing sleep associated

~1'lith

the excited mental states.

Gildea, Him<J"ioh, Hubbard and Fazikas (17 and 18)
in t·v'lO contributions have reviewed the changes produced
by various types of drugs in Schizophrenic patients.
They state that there is "indirect evidence advanced by
Reichardt, Kleist" Loewy and others to indicate that the
syndrome schizophrenia is due in large part to some
dysfunction of the brain stem."

Other observers lean

heavily on the possibility of a disturbance of the
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function in the centers in the mid-brain which control
the vegetatibe system, and the low basal metabolic rate
found in most schizophrenic patients may be determined
by this defective regulating mechanism.

However, there

is no evalua.tion of these hypotheses from any positive
findings from histopathological studies.

The writers of

this art iele used drugs that are most effect hre in dilating the superficial cerebral vessels (carbon dioxide
and histamine) but found that the results were not as
effective in producing lucid intervals as did sodium
amytal.

They concluded that:

"The favorable qhanges in

behavior of oatatonic schizophrenia patients to intravenous sodium amy tal are not dependent on the dilation
of cerebral vessels, on the rise in the carbon dioxide
content or a fall in the pH in the arterial blood."
They found that sodium amy tal had a "different and more
favorable effect, and longer duration than treatment by
anoxemia, high carbon dioxide concentration, or painful
stimuli.

Since sodium amy tal is a drug which acts pri-

marily in the brain stem, it is suggested that its effectiveness in rousing catatonic schizophrenic patients from
stupor lends some support to the hypothesis that the
symptoms of this disease are due in
tion of the brain stem."

par~

to a dysfunc-
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Dameshek, Meyerson and Loman (10) found that large
doses of sodium amy tal intravenously caused deep sleep,
fall in systolic pressure, fall in temperature averaging
1 degree F., marked diminution in B. M. R. averaging 26
per cent, and slight though definite diminution in "uptake" of oxygen and dextrose by the brain.

Small doses

caused the same effects, less in degree, with variable
effects on B. M. R.

They thought that the extreme

diminution in B. M. R. was "due pro"ba.bly to a combined
effect of sleep and a more specific effect of the drug
on brain (hypothalamic?) tissue."
Thorner (48 and 49) is of the opinion that "sodium
amy tal acts partly by inhibiting the activity of nerve
cells.

The various divisions of the nervous system are

affected in the order of their phylogenetic appearance,
i.e. tha latest are most easily affected.

The 'release

phenomena' observed may be explained by the inhibition
of higher inhibitory centers."

He explained that the

effects of intravenous sodium amy tal are transcient.
As far as mutism was concerned, only one out of eighteen
persisted in talking when sodium amy tal was discontinued,
but ten of these would talk for several days after daily
doses of 6 grains.

"Flexibilities cerea was nearly al-

ways relieved under the influence of sodium amy tal, but
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as the effects decrease, the symptoms return.

Delusions

and hallucinations were seldom helped."
Hoch(24) advocates the employment of prolonged continuous sleep by using mixtures of barbital compounds,
and maintaining the patient in a desired state of somnolence.

The patients are kept under the influence of the

drugs for an average duration of twenty days.

Signs of

barbital poisoning are watched for, and the patient is
tube fed with high calor iC, non-residue diet t1/iTO or three
times daily.

Fecal impactions are guarded against by

soap suds enemas, magnesium sulphate once per week, and
occasional feeding of two or three ounces of vegetable
oil.

"After this type of therapy, manic and depressed

patients awake, refreshed and rested, and with a considerable gain in weight.

Schizophrenic patients fre-

quently show the same type of improvement for from three
to ten days."
The use of dinitrophenol in Schizophrenia:
Looney and Hoskins (34) stated that McFarland had
suggested Ilthat partial deprivation of oxygen tends to
produce in normal subjects a number of the abnormalities of behavior that are seen also in the schizophrenia
picture.

These include defective judgment, depression of

the aut ocr it ical ability, retarded percept ion, perseverat ion,
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restriction in the field of attention, and deficiency of
ethical inhibitions.

Other schizophrenic traits occa-

sionally seen are silly laughter, anger without adequate
cause, destructiveness and mental confusion.

Psycholo-

gical tests under higher degrees of oxygen deficiency
have shown lack of skill in motor performance, increase
of discrimination time and slowness of association;
hallucinations, delusions and stupor have also been observed under these conditions."

They were .interested

to make a study of a drug, the essential effects of
which might stimulate oxidative processes.

They accord-

ingly subjected a group of ten patients to treatment
using dinitrophenol and later dinitro-ortho-cresol.
Their results were not made known at the time, because
the patients were still under active

thera~y.

Finkleman and Stephans (16) used dinitrophenol
treatment on 12 patients with dementia praecox.

The

average increase in oxygen consumption rate was 37.16.
The average loss of weight was 1.44 Ibs. per week.
"Two patients with a hypopituitary type of fat distribut ion did not respond t 0 dinitrophenol ,vi th either a
loss of weight or increased oxygen consumption.

The

oxygen consumption rates returned to the pre-treatment
values after the administration of the drug was
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discontinued.

The non-protein nitrogen and icteric in-

dex increased and blood cholesterol decreased during
treatment.

The icteric index and the cholesterol showed

a tendency to return to pre-treatment values, but the
non-protein nitrogen remained increased.
improved mentally.

Five patients

The increased attention given the

patients during treatment ca.rmot be ruled out as having
seen the chief agent in causing the mental improvement.
The reactions of dementia praecox patients to the administration of dinitrophenol together with oxygen should
be studied.

tI

Wishnofsky, Kane, 8hlevin and Byron (52) showed
that dinitrophenol "causes a significant ihcrease in the
concentration of the blood sugar.

The elevation of the

blood sugar level in hypersuprarenalism and other conditions in which there is an augumentation in heat production must in part be attributed to an increase in oxidative metabolism."
Gutting, Mehrtens, and Tainter (9) found that the
"outstanding actions of dinitrophenol are sustained increases in metabolism and body temperature, with enormous activity of all metabolic functions.

Doses within

therapeutic range cause in man significant increases in
metabolism without fever, which is useful in depressed
metabolic states."
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Statistics are wanting in this method of treatment
and its therapeutic value in schizophrenia.
Masserman and Goldsmith (36) believe that the drug
undoubtedly st imulates body metabol iSrtl, and, by inference, that of the central nervous system.

He states

that the best results were obtained in young individuals
suffering from first occurrences of retarded-apathetic
states.
There is reason to believe that the fever produced
by dinitrophenol is not the principle by which it pro-

duces its effects, if any.

Menzies (38) compared

treated and untreated cases of schizophrenia over a period of six years with the use of induced hyperpyrexia,
by use of milk injections and other methods and showed
that no increase in the recovery rate can be expected
from this treatment alone.
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SUMMARY

Dr. Manfred Sakel of Vienna first reported favorable
results of insulin hypoglycemia shock therapy in Schizophrenia in 1933.

Since then, he has instigated his

methods in Prof. Potzlts clinic, and his coworkers, Dr.
Karl Dussik and Dr. M. Muller, have approved them, and
the therapy has been adopted in private and public mental
hospitals in several nations.
The therapy consists in a progressive insulinization
of the patient through daily intramuscular injection of
increasing doses of insulin until the so-called shock
dose is neutralized after the lapse of a period of time
required by the individual case through the administration
of an adequate amount of carbohydrates.
The method is divided into four phases.

In phase 1,

insulin is given one to three times daily, 15 to 30 units
per dose, started on an empty st omaoh, and carbohydrates
are withheld for 4 hours.

According to the reaction at-

tained, the dose is increased each day by 5 to 10 units
until a hypoglycemia state with coma is reached.

This

begins phase 2, in which a daily dose is given in the
morning and consists of the same amount as that which
produced the first shock.
to the reaction.

This may be varied according

Usually doses of from 20 to 250 units

56

daily are used.

The effect is noticed three-quarters of

an hour to five hours after the injection.
are fed as before.

Carbohydrates

If treatment is to be terminated,

glucose may be given with a stomach tube or intravenously.
After a convulsion, the treatment is interrupted.

The

number of shocks depends on the amount of amelioration of
the psychosis obtained.

In phase 3, no insulin is given

for varying periods of time.
increased after severe shock.

This rest interval may be
During phase 4, the dose

of insulin is decreased or the carbohydrates are given
sooner after the injection of insulin.
During the insulin shock, the blood sugar level is
lowered.

Epinephrine and other antagonists to insulin

are brought into play due to body response in an effort
to restore the equilibrium.

Oxygen up-take in the brain

app;ears to be reduced, and at the same time, dextrose
metabolism in the brain is reduced.

(Whether or not

this is cause or effect is disputable).

Plasma chlor-

ides are reduced during hypoglycemia, and in dogs there
is possibly increased spinal fluid pressure.

The various

theories concerning the cause of shock symptonls embody
anoxemia of the brain tissue, hypersuperrenalism, disturbed water balance, and disturbed carbohydrate metabolism in the brain.

Evidence has been shown that
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decerebration or cervical section of the cord, as well as
section of a nerve will not produce motor symptoms of the
affected areas.
Hypoglycemic shock is characterized by a variety of
symptoms, both objectively and subjectively, ranging from
slight feelings of uncomfortableness with sweating and
pallor, to stuporous condition, convulsions and coma.
Complete amnesia accompanies deep shock.

There is dispute

concerning the histopathologic effects of repeated or
prolonged hyperinsulinism, but it is agreed that there
are some deleterious and permanent changes.

All sorts

of cortical, pyramidal, extrapyramidal and vagosympathetic

sJ~ptoms

accompany the advanced hypoglycemic state

before deep coma ensues.
Insulin shock therapy appears to suppress the abnormal psyche of the schizophrenic patient and tends to restore the normal intellect.

Then, too, there appears to

be a strong tendency to the fixation of the mental condition which exists at the time of the interruption of the
hypoglycemia.

Catatonic types of schizophrenia respond

least favorably to this therapy, while the paranoid patients repeatedly show the best progress.
The reports of Sakel, Muller and Dussik, which are
the most complete in the literature tenito show that
cases of less than six months' duration treated with his
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method were 89.8 per cent improved, including 73 per cent
completely cured.

In the cases of more than six months'

duration, 82 per cent were improved and 50 per cent completely cured.

In the cases of

mo~e

than eighteen months'

duration, 45 per cent were improved but only 0.5 per cent
completely cured.

These statistics covered over three

hundred pat ients,

These cor.iipared favorably with other

more incomplete reports of other observers.

Of these

104 cases, 15 remained well over a year and 34 over a
half year.

In the new cases, 3 of full remission, 5 of

good remission and 1 of social remission, have been followed by recurrence.

In the others, 42 of the new cases

show a good unchanging condition.

Among patients with

recurrences, five were retreated, three of whom gained
good remissions, one showed no results and one is still
being retreated.

Of those of the old cases with recur-

rence, 6 were retreated, 1 of whom gained a good remission, 1 a full remission, 2 social remissions, 1 showed
no results and 1 is still being treated.
Small amounts of insulin have proven of some value
in improving the appetite, increasing weight, and improving gastro-intestinal function in all psychoses.
Some evidence has been presented to indicate that
there is anbiologic antagonism between schizophrenia and
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epilepsy, and there are some very limited statistics to
indicate that intramuscular injeotions of camphor, and
metrazol intravenously will produce epileptiform convulsions in schizophrenia and produce remissions in excess
to spontaneous recovery_
Administration of carbon dioxide and other substances
which cause cerebral stimulation have produced periods
of lucid intervals in schizophrenia.

This disorder ap-

pears to be character ized by low' oxygen consumpt ion in
the brain, and low basal metabolic rates.

Carbon dioxide

appears to stimulate oxygen consumption in the cells and
reduces oxygen fixation in blood and plasma.
Prolonged narcosis in schizophrenia appears to have
favorable but transient effects.

Of the sedatives and

narcotics used, barbiturates, and especially, sodium amytal seem to be of the most value in producing the desired
effects.

Sodium amy tal is alleged by some authors to

act on the brain stem, where, by indirect evidence, the
schizophrenic syndrome may be due to a dysfunction. of
this structure.

Sodium amy tal causes a diminution of B.

M. R. and a diminution in oxygen and dextrose uptake in
the brain.

The lucid intervals produced by prolonged

sleep therapy rarely extend over a period of several
days.

Flexibilitas carea and 'other catatonic symptoms
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a.re relieved more specifically by sodium amy tal than
other types of schizophrenic reactions.
Dinitrophenol a&ninistered to patients with this
syndrome are aided transciently.

This drug increases

oxygen consumption rate, increase in concentration of
blood sugar, and increases metabolism, which is useful
in depressed metabolic states.

Here again, cases of

short standing are aided the most.
Pyretotherapy appears to have no value in schizophrenia.
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SUMMARY
1. The purpose of the insulin shock therapy is to place
the schizophrenic patient into a state of hypoglycemia by a regular series of insulin injections ...
2. Convulsions and coma is

r~gulated

by introduction of

glucose, orally or intravenously.
3. Insulin in large doses decreases the blood sugar level,
decreases oxygen and dextrose up-take in the brain,
and results in a variety of cortical, pyramidal, extrapyramidal and vagosympathetic symptoms.
4. Insulin shock therapy appears to suppress the abnormal
psyche of the schizophrenic patient and tends to restore his normal intellect.

The mechanism whereby

these results are brought about are not known.

The

weight of.evidence in the literature to date leans
toward the theory that it is due to a change of metabolism in the brain, especially of carbohydrates.
5. Remission of the symptoms of schizophrenia following
insulin hypoglycemia therapy are in marked excess to
spontaneous remissions, and the latter are prolonged.
Recent cases respond best to this therapy, the paranoid types receiving the most benefit, and the catatonic types the least.
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6. Small doses of insulin are valuable in depressed

metabolic states.
7. Of the other types of medicinal therapy, the barbiturates, and especially, sodium amy tal, have the most
value but the desired results are very transcient.
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